Table 2.

Induction of C5a-inhibitor activity in various fibroblast cultures by phorbol myristate acetate (PMA)

Culture Passages Number of cultures Number of experiments C5a inhibition (%)
−PMA +PMA
Peritoneal, normal  3-5 4  4  46.5 ± 6.6  40.3 ± 5.1  
Peritoneal, normal  5-6  4  1  14.1 ± 4.2  27.0 ± 7.1* 
Peritoneal, normal  6-12  9  15  1.5 ± 2.8 21.5 ± 2.7 
Peritoneal, FMF  3  3  −9.0 ± 0.9  3.0 ± 2.9  
Skin, normal  3-5  3  −3.3 ± 6.2  18.1 ± 6.6* 
Skin, FMF  3-5 2  6  8.4 ± 1.5  7.2 ± 0.7 
Culture Passages Number of cultures Number of experiments C5a inhibition (%)
−PMA +PMA
Peritoneal, normal  3-5 4  4  46.5 ± 6.6  40.3 ± 5.1  
Peritoneal, normal  5-6  4  1  14.1 ± 4.2  27.0 ± 7.1* 
Peritoneal, normal  6-12  9  15  1.5 ± 2.8 21.5 ± 2.7 
Peritoneal, FMF  3  3  −9.0 ± 0.9  3.0 ± 2.9  
Skin, normal  3-5  3  −3.3 ± 6.2  18.1 ± 6.6* 
Skin, FMF  3-5 2  6  8.4 ± 1.5  7.2 ± 0.7 

FMF indicates familial Mediterranean fever. C5a inhibition was measured as described (see footnote to Table 1) after culture induction with either PMA (100 nmol/L for 1 hour) or medium as described in “Materials and methods.” A490 readings for control myeloperoxidase release were 0.21 to 0.64. For each FMF culture with or without PMA, a normal control culture at the same passage was assayed.

*

P < .05 (versus noninduced cultures).

P < .001 (versus noninduced cultures).

Close Modal

or Create an Account

Close Modal
Close Modal